ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Pharmaron Beijing Co., Ltd. ?
1
With ROE of 9.15%, it has a Very Expensive valuation with a 0.40 Price to Book Value
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 48.80%, its profits have fallen by -29.7%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Pharmaron Beijing Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Pharmaron Beijing Co., Ltd.
48.8%
2.14
63.80%
Hang Seng Hong Kong
27.36%
1.06
25.88%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
22.77%
EBIT Growth (5y)
14.32%
EBIT to Interest (avg)
18.63
Debt to EBITDA (avg)
0.75
Net Debt to Equity (avg)
0.21
Sales to Capital Employed (avg)
0.59
Tax Ratio
17.61%
Dividend Payout Ratio
19.91%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
13.47%
ROE (avg)
12.92%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
4
Industry P/E
Price to Book Value
0.40
EV to EBIT
4.45
EV to EBITDA
2.76
EV to Capital Employed
0.50
EV to Sales
0.67
PEG Ratio
NA
Dividend Yield
1.05%
ROCE (Latest)
11.28%
ROE (Latest)
9.15%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Pharmaron Beijing Co., Ltd.
Operating Cash Flow - Annually
Highest at HKD 3,097.33 MM and Grown
each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (HKD MM)
Profit After Tax (PAT) - Quarterly
Highest at HKD 504 MM.
in the last five periodsMOJO Watch
Near term PAT trend is positive
PAT (HKD MM)
Earnings per Share (EPS) - Quarterly
Highest at HKD 0.28
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (HKD)
Cash and Cash Equivalents - Half Yearly
Highest at HKD 6,516.76 MM
in the last six half yearly periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents (HKD MM)
Here's what is not working for Pharmaron Beijing Co., Ltd.
Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at HKD 379 MM.
in the last five periodsMOJO Watch
Near term PBT trend is negative
PBT less Other Income (HKD MM)
Non Operating Income - Quarterly
is 36.41 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model
Non Operating Income to PBT (HKD MM)
Inventory Turnover Ratio- Half Yearly
Lowest at 11.39 times
in the last five half yearly periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Debtors Turnover Ratio- Half Yearly
Lowest at 4.38 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio
Non Operating Income - Quarterly
Highest at HKD 217 MM
in the last five periodsMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income (HKD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
